Target intelligence / Profile preview

Damaged mucosal proteins

Molecular classification
Other
01

Overview

Damaged mucosal proteins refer to the proteinaceous exudate, primarily consisting of albumin, fibrinogen, and globulins, that is exposed at the site of gastrointestinal mucosal injury such as ulcers or erosions (StatPearls, 2023). These proteins serve as a localized therapeutic target for cytoprotective agents, most notably sucralfate and bismuth-containing compounds (DrugBank, 2024). In an acidic environment, sucralfate undergoes polymerization to form a negatively charged, viscous paste that binds to the positively charged proteins within the damaged tissue (PubChem, 2024). This interaction creates a physical barrier that shields the underlying mucosa from the corrosive effects of gastric acid, pepsin, and bile salts, thereby promoting tissue repair and healing. While not a single molecular entity, this protein complex is a well-recognized pharmacological target in the treatment of acid-peptic disorders.

Other names
Exudate proteinsUlcer base proteinsNecrotic tissue proteinsMucosal exudateExposed mucosal proteins
02

Mechanism of action

Formation of a physical cytoprotective barrier through ionic binding to exposed proteins at the site of mucosal injury.

03

Biological functions

Structural integrityInflammatory responseWound healing
04

Disease associations

Peptic ulcer diseaseGastritisGastroesophageal reflux disease (GERD)Mucositis
05

Safety considerations

Aluminum toxicity in patients with chronic renal failureBezoar formationConstipationInterference with absorption of other drugs (e.g., fluoroquinolones, digoxin)
06

Interacting drugs

Sucralfate

2 more in the full profile.

07

Biomarkers

Endoscopic visualization of mucosal lesionsGastric pH

Beyond the preview

Go deeper on Damaged mucosal proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Damaged mucosal proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call